Mexico City, Mexico — Mexico has passed the 100 million vaccine mark with anticipations of reaching 150 million by year end. With the latest shipment of over 4 million AstraZeneca vaccines earlier this week, the country passed the 100-million-mark of vaccines received.
Foreign Minister Marcelo Ebrard reported that Mexico has reached the 100 million vaccine mark, and that during the month of September, the country will receive two more shipments. One of 1.75 million doses of Moderna and 4.6 million doses of AstraZeneca.
During the morning press conference, Ebrard pointed out that the president invited his Argentine counterpart, Alberto Fernández, to finalize the production of the AstraZeneca vaccine (in Mexico) between Mexico and Argentina.
“This strategy is what led us to have the number of vaccines we have today and, at the national level, to produce or package AstraZeneca and CanSino,” said Ebrard.
At the bilateral level, the secretary highlighted the 20 million vaccines that China sent through Sinovac, the production in Mexico of CanSino, the US donations for more than 5 million vaccines and the 870,000 doses India sent in February.
Before signing off, Ebrard noted that Mexico has approved Phase III trials for Walvax and Sanofi, which are in addition to the approved trials of CanSino, Janssen, Novavax and CureVac.
He also said that the Committee for New Molecules has recently issued a “favorable opinion” for the emergency use of the Cuban vaccine Abdala.